BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Biotech Bay

  Gamma Biosciences Launches Initiative Through Mirus Bio to Develop Lipid-Polymer Nanocomplexes for In Vivo mRNA Delivery

  Gamma Biosciences, a global life sciences company serving the advanced therapy market, today announced an initiative through its subsidiary Mirus Bio, a leader in nucleic acid delivery technology, to develop novel, highly active lipid-polymer nanocomplexes for therapeutic mRNA delivery in vivo.

  March 23, 2022

   · 

  3 min read
• Biotech Beach

  PHYLEX BIOSCIENCES PUBLISHES POSITIVE RESULTS OF PROTECTION STUDY AGAINST SARS-CoV-2 DELTA VARIANT WITH ITS SECOND-GENERATION mRNA VACCINE

  Two years into the COVID-19 pandemic there is still a need for vaccines to effectively control the spread of novel SARS-CoV-2 variants and associated cases of severe disease.

  March 23, 2022

   · 

  2 min read
• Sobi to cease ReFacto manufacturing in the first quarter of 2024

  Sobi® announced that its contract with Pfizer for the manufacture of drug substance for ReFacto AF®/Xyntha® has been amended due to clarity of final order volumes and will now expire in the first quarter of 2024, earlier than the previous expiry date at the end of 2025.

  March 23, 2022

   · 

  2 min read
• Business

  Cyclica and Arctoris to Expand Partnership to Advance Drug Discovery Programs for Alzheimer’s Disease

  Cyclica Inc., and Arctoris Ltd. have agreed to expand their partnership to progress drug discovery programs for novel neurodegenerative targets with a focus on Alzheimer’s disease.

  March 23, 2022

   · 

  3 min read
• Business

  Center for Breakthrough Medicines Appoints John Lee, Ph.D. as Vice President, Head of Cell Therapy

  The Center for Breakthrough Medicines announced the appointment of John Lee, Ph.D. to Vice President, Head of Cell Therapy.

  March 23, 2022

   · 

  3 min read
• Transdermal Skin Patch Market Clinical Research Patch Sales Forecast 2028

  Global Transdermal Patch Market, Dosage, Price & Clinical Trials Insight 2028 Report Highlights.

  March 23, 2022

   · 

  4 min read
• Platelet Derived Growth Factor Receptor PDGFR Inhibitors Drug Market 2028

  Global PDGFR Inhibitors Market, Drug Sales and Clinical Trials Insight 2026 Report Analysis and Data Highlights.

  March 23, 2022

   · 

  4 min read
• US Cancer Biosimilar Market Insight 2028

  “US Cancer Biosimilar Market Opportunity, Drug Dosage, Price & Clinical Trials Insight 2026" Report highlights.

  March 23, 2022

   · 

  4 min read
• Mitogen Activated Protein Kinase Enzymes MEK Inhibitors Market Drug Sales Insight 2026

  Global MEK Inhibitors Market, Drug Sales & Clinical Trials Insight 2026 Report Analysis & Data Highlights.

  March 23, 2022

   · 

  4 min read
• Biomarkers for Alzheimer’s Disease

  Global Alzheimer’s Disease Biomarkers & Clinical Trials Insight 2028 Report Highlights.

  March 23, 2022

   · 

  3 min read